Skip to main content
NIH funding notice PA-16-425

"High" or "Medium" Priority AIDS Research on Non-AIDS-defining or AIDS-defining Cancers (R21)

Closed on September 7, 2019.

Posted
September 7, 2016
Close date
September 7, 2019
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

8 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1,639,847 in first-year total cost, median $210,563.

Most frequent study sections

  1. HIV Coinfections and HIV Associated Cancers Study Section[HCAC]3
  2. AIDS Clinical Studies and Epidemiology Study Section[ACE]1
  3. AIDS-associated Opportunistic Infections and Cancer Study Section[AOIC]1
  4. Special Emphasis Panel[ZRG1 AARR-K (02)]1
  5. Special Emphasis Panel[ZRG1 AARR-M (03)]1

Most frequent institutions

  1. JOHNS HOPKINS UNIVERSITY2
  2. TULANE UNIVERSITY OF LOUISIANA1
  3. UNIV OF NORTH CAROLINA CHAPEL HILL1
  4. UNIVERSITY OF CALIFORNIA LOS ANGELES1
  5. UNIVERSITY OF SOUTHERN CALIFORNIA1
Competing awards under PA-16-425 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2020Clonal Immunoglobulin DNA and Lymphoma Diagnosis1R21CA232891-01A1AMBINDER, RICHARD FREDERICKXIAN, RENAJOHNS HOPKINS UNIVERSITY, MD$175,110HCAC
2019Assessing the EBV circular RNAome1R21CA236549-01A1FLEMINGTON, ERIK KTULANE UNIVERSITY OF LOUISIANA, LA$230,279HCAC
2019Cellular Requirements for KSHV Latency in Endothelial Cells1R21CA240479-01A1LAGUNOFF, MICHAELUNIVERSITY OF WASHINGTON, WA$217,546ZRG1
2019Structure-guided development of chemical inhibitors against Kaposi’s sarcoma-associated herpesvirus (KSHV)1R21CA240154-01SUN, RENUNIVERSITY OF CALIFORNIA LOS ANGELES, CA$203,580HCAC
2019Translation initiation factor targeting by HHV-8 vIRF-11R21CA228678-01A1NICHOLAS, JOHNJOHNS HOPKINS UNIVERSITY, MD$178,078ZRG1
2019A novel cervical cancer screen-and-treat demonstration project with HPV self-testing and thermocoagulation for HIV-infected women in Malawi1R21CA236770-01CHINULA, LAMECKUNIV OF NORTH CAROLINA CHAPEL HILL, NC$164,430ACE
2018Regulation of lymphangiogenesis by KSHV vIRF31R21DE027888-01JUNG, JAE UUNIVERSITY OF SOUTHERN CALIFORNIA, CA$247,500ZRG1
2017Defining the Cellular Oncogenome of Kaposi Sarcoma1R21CA206851-01A1CESARMAN, ETHELPHIPPS, WARRENWEILL MEDICAL COLL OF CORNELL UNIV, NY$223,324AOIC

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

PA-16-425: "High" or "Medium" Priority AIDS Research on Non-AIDS-defining or AIDS-defining Cancers (R21) | ScienceDex | ConductScience